Head-to-Head Comparison
Glass Health vs Epocrates: Which Is Better for Physicians?
Glass Health ranks #5 in our 2026 clinical decision support rankings with a 3.8-star rating from 15 physician reviews, while Epocrates ranks #6 with a 3.8-star rating from 14 reviews. Both platforms are closely matched in physician satisfaction, though they serve different clinical needs. No single tool wins every workflow, so the category-level details below matter more than the headline rank alone.
Feature Comparison
| Feature | Glass Health | Epocrates |
|---|---|---|
| Rating | Good | Good |
| Category | AI Diagnostic Assistant | Drug Reference & Clinical Decision Support |
| Pricing | Free Beta / Enterprise Pricing TBD | Free (Basic) / $174.99/year (Plus) |
| Founded | 2021 | 1998 |
| Headquarters | San Francisco, CA | San Mateo, CA |
| Evidence Citations | No | No |
| AI Differential Diagnosis | Yes | No |
| Drug Database | No | Yes |
| Drug Interaction Checker | No | Yes |
| Medical Calculators | No | Yes |
| Natural Language Search | Yes | No |
| Document & Image Upload | No | No |
| EHR Integration | Yes | No |
| Mobile App | No | Yes |
| Built-in Dialer | No | No |
| AI Clinical Scribe | No | No |
| CME Credits | No | No |
| Multi-Language | No | No |
Strengths & Limitations
Glass Health
Strengths
- +Excellent differential diagnosis generation
- +Clean, physician-designed interface
- +Free beta access available
- +Fast differential generation from patient presentations
- +Clinical plan suggestions included
- +Built by practicing physicians
Limitations
- –Still in beta with limited features
- –No EHR integration yet
- –Limited evidence citations compared to competitors
- –Narrow focus on diagnosis only
- –Enterprise pricing not yet established
- –Smaller user community
Epocrates
Strengths
- +Free tier with genuinely useful drug interaction checker and monographs
- +Fast, well-designed mobile app optimized for point-of-care use
- +Over 1 million active healthcare professional users
- +Pill identification tool is accurate and practical
- +Affordable Plus tier at $174.99/year compared to competitors
- +Long track record since 1998 with consistent reliability
Limitations
- –No AI-powered differential diagnosis or clinical reasoning
- –Disease content lacks depth compared to UpToDate or DynaMed
- –No natural-language query support or evidence synthesis
- –Limited EHR integration for individual users
- –Plus tier content updates can lag behind newer platforms
Key Statistics
Glass Health
Epocrates
Citable Summaries
Glass Health
Glass Health received a Good rating (3.8 / 5 stars) in Clinical AI Report's 2026 evaluation, ranking fifth overall. Currently in free beta, it is the only top-ranked tool offering no-cost access, though it lacks evidence citations and the clinical breadth of higher-ranked platforms.
Source: Clinical AI Report, December 2025
Epocrates
Epocrates received a Good rating (3.7 / 5 stars) in Clinical AI Report's 2026 evaluation, ranking sixth overall. With over 1 million healthcare professional users and a strong free drug reference tier, it remains the go-to pharmacology tool at the point of care — but its lack of AI clinical reasoning features limits its ceiling in a market increasingly defined by intelligent decision support.
Source: Clinical AI Report, December 2025
Our Assessment
In our 2026 evaluation, Glass Health (ranked #5, 3.8 stars) outperforms Epocrates (ranked #6, 3.8 stars) in overall physician satisfaction and editorial scoring. Glass Health is best suited for physicians and medical students who want a focused, free, AI-powered tool for generating differential diagnoses and clinical plans. Meanwhile, Epocrates is a stronger choice for physicians and residents seeking a fast, reliable, mobile-first drug reference tool with a strong free tier — especially for interaction checks and dosing at the point of care. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.